SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-052351
Filing Date
2020-09-29
Accepted
2020-09-29 16:48:42
Documents
1
Period of Report
2020-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5850
  Complete submission text file 0001209191-20-052351.txt   7462
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Issuer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210
Business Address WELLINGTON ALTERNATIVE INVESTMENTS LLC 280 CONGRESS STREET BOSTON MA 02210 (617) 951-5372
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (Reporting) CIK: 0001787092 (see all company filings)

State of Incorp.: E9
Type: 4 | Act: 34 | File No.: 001-39539 | Film No.: 201209449